GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NatureCell Co 007390.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

21,800

-0.46%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩20.73bn

FY2016FY2025

Net income

−₩2.84bn

FY2016FY2025

Free cash flow

−₩16.43bn

FY2016FY2025

Shareholders' equity

₩63.03bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩20.73bn₩32.33bn₩19.35bn₩21.25bn₩22.20bn₩16.72bn₩23.07bn₩26.72bn₩27.22bn₩26.79bn
Research and development₩64.4m₩338.9m₩2.22bn₩1.58bn₩1.42bn₩1.69bn——₩150.3m₩30.9m
Operating income−₩3.62bn₩575.2m−₩11.11bn−₩6.94bn——₩1.01bn₩2.34bn−₩1.20bn−₩3.68bn
Net income−₩2.84bn₩1.23bn−₩11.68bn−₩6.81bn−₩32.03bn−₩18.87bn₩902.0m₩2.23bn−₩460.7m−₩3.22bn
Diluted earnings per share-44.0519.05-182.06-108.78-511.45-308.3814.7439.36-8.15-59.29

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩74.73bn₩72.00bn₩68.40bn₩94.02bn₩69.65bn₩85.75bn₩93.11bn₩52.88bn₩51.44bn₩52.67bn
Cash and short-term investments—₩28.37bn₩29.89bn₩31.26bn₩32.55bn₩48.50bn₩46.28bn₩14.87bn₩9.34bn₩3.46bn
Total liabilities₩11.70bn₩7.37bn₩6.98bn₩36.86bn₩8.80bn₩23.07bn₩11.22bn₩9.75bn₩11.96bn₩18.65bn
Debt—₩1.78bn₩2.31bn₩6.68bn₩2.54bn₩14.27bn₩5.58bn₩4.11bn₩4.16bn₩8.53bn
Shareholders' equity₩63.03bn₩64.62bn₩61.42bn₩57.16bn₩60.85bn₩62.68bn₩81.89bn₩43.13bn₩39.48bn₩34.02bn
Shares outstanding64m64m64m63m63m61m61m57m57m54m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩156.7m₩1.51bn−₩2.13bn−₩14.87bn−₩10.15bn−₩5.41bn₩357.5m₩3.70bn₩5.29bn−₩2.14bn
Capital spending−₩16.59bn−₩3.12bn−₩6.12bn−₩3.80bn−₩455.4m−₩2.72bn−₩1.42bn−₩413.7m−₩631.9m−₩2.00bn
Free cash flow−₩16.43bn−₩1.61bn−₩8.25bn−₩18.66bn−₩10.61bn−₩8.13bn−₩1.07bn₩3.29bn₩4.66bn−₩4.14bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩6.20bn₩4.06bn₩6.35bn₩3.90bn₩6.40bn₩4.08bn₩7.74bn₩5.82bn
Operating income−₩701.6m−₩1.32bn−₩260.9m−₩1.39bn−₩369.5m−₩1.71bn₩185.5m−₩987.9m
Net income−₩637.1m−₩1.14bn₩339.7m−₩1.27bn−₩667.8m−₩1.24bn₩311.3m−₩539.1m
Diluted earnings per share-9.89-17.735.27-19.71-10.36-19.274.84-8.38
Cash from operations−₩3.25bn−₩766.0m₩490.0m−₩3.28bn₩4.52bn−₩1.57bn₩1.51bn₩209.0m
Capital spending−₩618.0m−₩20.0m−₩14.97bn−₩122.0m−₩64.0m−₩1.44bn−₩3.12bn−₩2.90bn
Free cash flow−₩3.87bn−₩786.0m−₩14.48bn−₩3.40bn₩4.46bn−₩3.01bn−₩1.61bn−₩2.69bn
Total assets₩88.56bn₩86.75bn₩74.73bn₩71.32bn₩72.01bn₩70.82bn₩72.00bn₩70.87bn
Cash and short-term investments—————₩22.93bn₩28.37bn₩24.84bn
Debt—————₩1.01bn₩1.00bn₩1.03bn
Shareholders' equity₩62.94bn₩63.09bn₩63.03bn₩62.72bn₩63.65bn₩63.51bn₩64.62bn₩64.12bn

Financial ratios

Data as of 29 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016
Operating margin-17.5%1.8%-57.4%-32.6%———4.3%-13.6%
Net margin-13.7%3.8%-60.4%-32.1%-144.3%-112.9%———
Return on equity-4.5%1.9%-19.0%-11.9%-52.6%-30.1%———
Return on assets-3.8%1.7%-17.1%-7.2%-46.0%-22.0%———
Free cash flow yield———————0.4%—
Revenue growth-35.9%67.1%-8.9%-4.3%32.8%-27.5%———
Earnings growth-331.5%-110.5%71.4%-78.7%69.7%-2192.0%———
Current ratio3.32x10.19x9.64x1.88x6.52x2.75x———
Debt to equity—0.00x0.00x0.00x0.00x0.07x0.03x——
Equity ratio84.3%89.8%89.8%60.8%87.4%73.1%———
Interest coverage-18.06x3.42x-9.68x-4.02x—————
R&D as a share of sales0.3%1.0%11.5%7.4%6.4%10.1%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.8%4.4%-3.8%
Operating income-19.5%—11.5%
Net income-25.3%-31.5%7.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-5.7%-22.5%——
Net margin-3.0%-21.5%-53.6%-27.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-494.9—-43.9-140.2-34.8-33.2447.1282.5-2643.1-73.4
Price to sales67.842.826.545.050.237.517.523.644.88.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2.8-to-1 reverse split · 29 Aug 2008
  • 21-for-20 split · 2 Jan 2001
  • 10-for-1 split · 24 Apr 2000
  • 21-for-20 split · 4 Jan 2000
  • 1.104-for-1 split · 22 Nov 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.